We’re excited to see you in San Diego as we unveil our new Coronary IVL catheter and explore the engineering behind our relentless evolution of IVL.
Join us as we spark discussion and share findings that will energize your daily practice.
Learning objectives:
This section contains attributions including profile pictures, titles, descriptions, and Twitter handles.
Learning objectives:
Learning objectives:
Learning objectives:
Learning objectives:
Learning objectives:
Learning objectives:
Learning objectives:
Learning objectives:
Learning objectives:
Learning objectives:
Learning objectives:
This section contains attributions including profile pictures, titles, descriptions, and Twitter handles.
Join us for an exclusive customer event during TCT, hosted by Dr. Nick West, CMO, Shockwave Medical, and Dr. Carlos Collet, Director of Cardiovascular Imaging, Physiology, and Translational Therapeutics at CRF.
Hear from the Shockwave R&D team about the research, design, and the behind the scenes development that enables physicians to more efficiently and effectively treat their most challenging patients. Drawing on real world feedback that shaped our Shockwave C2 Aero platform, the session will highlight how these innovations are taking treatment of coronary calcium further, faster.
This section contains attributions including profile pictures, titles, descriptions, and Twitter handles.
Presenter: Sahil A. Parikh
Location: Ground Level | Halls C-G | Station 2
Presenter: Prakriti Gaba
Location: Ground Level | Halls A-B | Coronary Live Case Theater
Presenter: Robert W. Yeh
Location: Ground Level | Halls A-B | Coronary Live Case Theater
Presenter: Ziad A. Ali
Location: Ground Level | Halls C-G | Station 8
Presenter: Rhian E. Davies
Location: Ground Level | Halls C-G | Station 8
Presenter: Robert W. Yeh
Location: Ground Level | Halls C-G | Station 9
COSIRA II is a multicenter, randomized, double-blind, sham-controlled trial designed to evaluate Shockwave Reducer, a novel therapeutic option for treating refractory angina pectoris. Learn more about this exciting trial, including target patients and participating sites in the U.S. and United Kingdom.1
All presenting physicians are paid consultants of Johnson & Johnson MedTech.
Caution: In the United States, Shockwave Reducer is an investigational device, limited by United States law to investigational use. The Reducer is subject of Investigational testing and is being studied in the COSIRA-II trial in Canada.
1 Shockwave Reducer is commercially available in certain countries outside the U.S. and Canada. Please contact your local representative for specific country availability. Prior to use, please reference the Instructions for Use for more information on warnings, precautions and adverse events: ifu.sw-reducer.com